---
$id: https://graph.org.ai/products/commodity/51432314
$type: Product
source: UNSPSC
code: "51432314"
title: "Moxonidine hydrochloride"
class: "51432300"
classTitle: "Antihypertensive imidazoles"
family: "51430000"
familyTitle: "Antihypertensive drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Moxonidine hydrochloride

**UNSPSC Code**: 51432314
**Class**: [Antihypertensive imidazoles](Antihypertensive imidazoles.mdx)
**Family**: [Antihypertensive drugs](../Antihypertensive drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antihypertensive agent with the molecular formula C9H12ClN5O.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5RYW07SK5E, chemically known as 4-chloro-n-(4,5-dihydro-1h-imidazol-2-yl)-6-methoxy-2-methyl-5-pyrimidinamine hydrochloride, but more generally known as moxonidine hydrochloride, which bears US NIH Compound Identifier 156339. European Medicines Agency schedules moxonidine hydrochloride or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09092MIG. Most nations, for tariff purposes, schedule moxonidine hydrochloride under HS 29335995. SMILES: CC1NC(C(C(N1)CL)NC2=NCCN2)OC.CL.

